NVOS Stock Forecast 2025: Price Outlook, Risks & Facts
Looking for an NVOS stock forecast 2025 that gives you a number? I’ll be upfront: nobody can responsibly give you one. NVOS, the ticker for Novo Integrated Sciences, now trades on the over-the-counter market at fractions of a cent. There are no analyst price targets, and the daily swings are huge. What this page does give you is the full picture: where the stock stands, how it got here, and what could move it from here.
This is general information, not financial advice. NVOS is extremely high risk, so check live quotes and the company’s SEC filings before you act.
What Is NVOS and What Does the Company Do?
Novo Integrated Sciences is a healthcare company with its main operations in Canada. Its clinics provide physiotherapy, chiropractic care, occupational therapy, eldercare, massage therapy, acupuncture and concussion management. It reports two segments, healthcare services and product sales, and most of its revenue comes from the clinics. The company was formerly called Turbine Truck Engines, and its U.S. office is in Bellevue, Washington.
Our comprehensive overview of Novo Integrated Sciences covers the business in more depth. We also looked at the biotech angle and Novosanis for readers who want that side of the story.
NVOS Stock at a Glance
| Item | Latest picture |
| Company | Novo Integrated Sciences, Inc. |
| Ticker | NVOS |
| Where it trades | OTC market (moved from Nasdaq on Nov 6, 2024) |
| Recent price | Roughly $0.004 in late September 2026 |
| 52-week range | About $0.0001 to $0.06 |
| Market cap | Under $100,000 on most trackers |
| Analyst price target | None published |
| Dividend | None |
| Core business | Multidisciplinary primary care clinics in Canada |
Prices at this level move on a handful of trades, so treat any figure here as a snapshot and not a live quote.
How We Got Here: The Nasdaq Exit
You can’t build a sensible NVOS stock forecast 2025 without this part. In February 2024, Nasdaq told the company its share price had fallen below the $1.00 minimum bid requirement. The company didn’t regain compliance by the August 2024 deadline, and it didn’t qualify for another extension. Trading was suspended on Nasdaq at the open on November 6, 2024, and the shares moved to the OTC market. In April 2025, Nasdaq said it would file the paperwork to complete the delisting.
Around the same time, a planned $60 million gemstone collection purchase was cancelled. That deal had briefly given the story some excitement, and its collapse removed it. Our write-up on the volatility behind the NVOS stock price walks through the earlier swings.
NVOS Stock Forecast 2025: Three Scenarios
Without analyst coverage, the honest approach is to describe conditions, not invent targets. Here is how the scenarios look.
| Scenario | What would need to happen | What it likely means for the price |
| Bullish | Clear revenue growth, a credible path to profit, fresh financing on fair terms, current SEC filings | A sharp rebound from a tiny base is possible, though still volatile |
| Base case | Clinics keep operating, losses continue, little news | Sub-penny trading with thin volume and random spikes |
| Bearish | More dilution, filing delays, cash pressure, loss of OTC tier | Further decline, with real risk of near-total loss |
I find the base case the most believable, and it’s not exciting. A stock this small can jump several hundred percent in a day on a few thousand shares, then give it all back. That is a liquidity effect, not a signal.
If you want the longer view, read our NVOS stock forecast for 2026 and the NVOS stock price prediction page. Both use the same facts with a different time frame.
What Could Move NVOS Stock?
Several things matter more than chart patterns:
- Financial filings: Revenue was around $13 million on one data aggregator, with cash under $1 million. Check the latest 10-K and 10-Q for the real numbers.
- Dilution: Small companies often raise money by issuing shares, which pushes the price down.
- OTC tier and reporting status: Staying current with SEC filings keeps the stock visible to brokers and investors.
- Clinic performance: Patient volumes and margins in Canada drive the actual business.
- Social chatter: Penny stocks react to online hype. Browse what traders say on the NVOS stock message board or in our NVOS Stocktwits roundup, but remember that posts are opinions, not evidence.
Is There an NVOS Price Target?
Not from any major analyst firm. Sites that list a target for NVOS are usually generating it from a formula. If you want to see how people frame possible levels, our NVOS stock price target analysis explains the logic and its limits.
How to Research NVOS Before You Invest
- Pull the latest quote from your broker, since many don’t even allow sub-penny OTC buys.
- Read the most recent annual and quarterly reports on SEC EDGAR.
- Look at the share count over time to spot dilution.
- Check average daily volume. If you can’t sell easily, the price on screen means little.
- Only risk money you can afford to lose entirely.
FAQs About NVOS Stock Forecast 2025
What is the NVOS stock forecast for 2025?
There is no reliable analyst forecast. The stock trades at sub-penny levels on the OTC market, and outcomes range from a speculative rebound to further losses. Scenarios are more useful than a single number.
Is NVOS still listed on Nasdaq?
No. Trading moved to the OTC market on November 6, 2024, after the company failed to meet Nasdaq’s $1.00 minimum bid rule. Nasdaq later said it would complete the formal delisting.
Will NVOS stock go up?
It could spike on low volume at any time, but a lasting rise would need real improvement in revenue, profitability and financing. Nobody can promise that.
Does NVOS pay a dividend?
No. The company doesn’t currently pay one.
What does Novo Integrated Sciences actually do?
It runs clinics that provide physiotherapy, chiropractic care, occupational therapy, eldercare and related services, mainly in Canada.
Is NVOS a good investment?
It’s a very high-risk penny stock. Anyone considering it should read the filings, understand dilution and be ready for a total loss.
Conclusion
The NVOS stock forecast 2025 comes down to one point: this is a distressed, thinly traded stock with a real operating business behind it, and no analyst is putting a price on it. Delisting from Nasdaq, sub-penny pricing and cash constraints all point to caution.
The bullish case needs proof in the filings, not forum buzz. If you keep following the stock, start with the 2026 forecast, compare it with the price prediction, and verify everything against primary sources.
